MAIA Biotechnology (MAIA) Exchange Rate Effect (2022 - 2026)
MAIA Biotechnology's (MAIA) quarterly Exchange Rate Effect came in at -$2224.0 in Q2 2026, down 126.56% year-over-year from $8373.0 in Q2 2025, and down 115.79% quarter-over-quarter from $14086.0 in Q1 2026.
Powered by 
Analysis
MAIA Biotechnology (MAIA) Exchange Rate Effect (2022 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Exchange Rate Effect for 5 consecutive years, with -$2224.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 126.56% year-over-year to -$2224.0 in Q2 2026; TTM through Jun 2026 was -$4783.0, a 21.02% increase from a year earlier, with the FY2025 full-year figure at -$5216.0, up 75.79% from the prior year.
- Exchange Rate Effect was -$2224.0 for Q2 2026 at MAIA Biotechnology, down from $14086.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $29904.0 in Q4 2022 and troughed at -$26258.0 in Q3 2022.
- A 5-year average of -$1080.3 and a median of -$1696.5 in 2024 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 469.6% in 2024, down 224.4% in 2024.
- Over 5 years, Exchange Rate Effect stood at $29904.0 in 2022, then tumbled by 56.14% to $13116.0 in 2023, then sank by 224.4% to -$16316.0 in 2024, then gained by 4.35% to -$15606.0 in 2025, then soared by 85.75% to -$2224.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$2224.0 (Q2 2026), $14086.0 (Q1 2026), and -$15606.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | MAIA Biotechnology | 79.34 Mn | 51.74 Mn | - | -2,224.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,224.00 |
| Mar 31, 2026 | 14,086.00 |
| Dec 31, 2025 | -15,606.00 |
| Sep 30, 2025 | -1,039.00 |
| Jun 30, 2025 | 8,373.00 |
| Mar 31, 2025 | 3,056.00 |
| Dec 31, 2024 | -16,316.00 |
| Sep 30, 2024 | -1,169.00 |
| Jun 30, 2024 | 5,434.00 |
| Mar 31, 2024 | -9,494.00 |
| Dec 31, 2023 | 13,116.00 |
| Sep 30, 2023 | -10,221.00 |
| Jun 30, 2023 | 954.00 |
| Mar 31, 2023 | -3,966.00 |
| Dec 31, 2022 | 29,904.00 |
| Sep 30, 2022 | -26,258.00 |
| Jun 30, 2022 | -3,794.00 |
| Mar 31, 2022 | -4,282.00 |